CXCL8 and rheumatoid arthritis: In this study, the efficacy of PLAG in the suppression of IL-6 and MIP-2 (IL-8 or CXCL8) expression, which stimulates neutrophil migration, and its therapeutic effect on RA treatment were demonstrated (Figure 1 and 2).